68Ga PET/CT Imaging in Breast Cancer Patients
Phase 1
Recruiting
- Conditions
- Breast Cancer
- First Posted Date
- 2022-11-18
- Last Posted Date
- 2022-11-18
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT05622227
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, China
99mTc-MIRC213 SPECT/CT for the Detection of HER2-positive Breast Cancer
- First Posted Date
- 2022-11-18
- Last Posted Date
- 2022-11-21
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT05622240
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China
A Cohort Study on Screening and Follow-up of High-risk Population of PDAC Based on EUS
Not yet recruiting
- Conditions
- Carcinoma, Pancreatic Ductal
- Interventions
- Device: Endoscopic ultrasoundProcedure: EUS-Fine needle aspiration
- First Posted Date
- 2022-11-18
- Last Posted Date
- 2024-04-09
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 900
- Registration Number
- NCT05621824
Vinegar-induced Collection of Duodenal Pancreatic Juice Via Endoscopic Ultrasound
Not Applicable
Recruiting
- Conditions
- Pancreatic Cancer
- Interventions
- First Posted Date
- 2022-11-16
- Last Posted Date
- 2024-12-18
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 75
- Registration Number
- NCT05617872
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China
177Lu-PSMA-EB-01 in Patients With Metastatic Castration-resistant Prostate Cancer
Not Applicable
Recruiting
- Conditions
- Metastatic Castration-resistant Prostate Cancer
- Interventions
- Drug: 1.11 GBq (30 mCi) of 177Lu-PSMA-EB-01Drug: 1.85 GBq (50 mCi) of 177Lu-PSMA-EB-01Drug: 2.59 GBq (70 mCi) of 177Lu-PSMA-EB-01
- First Posted Date
- 2022-11-14
- Last Posted Date
- 2024-07-10
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 9
- Registration Number
- NCT05613738
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China
Characterizing Breast Cancer With 18F-FES PET/CT
Not Applicable
Recruiting
- Conditions
- Breast Cancer
- Interventions
- Diagnostic Test: 18F-FES PET/CT scan
- First Posted Date
- 2022-11-14
- Last Posted Date
- 2022-11-14
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT05613270
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China
Cross-sectional Follow-up on Digestive and Social Functions of SPN
Recruiting
- Conditions
- Solid Pseudopapillary Tumor of the PancreasPancreas Cancer
- Interventions
- Other: observational study
- First Posted Date
- 2022-11-03
- Last Posted Date
- 2022-11-03
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 300
- Registration Number
- NCT05604716
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China
177Lu-P17-087/177Lu-P17-088 in Patients With Metastatic Castration-resistant Prostate Cancer
Early Phase 1
Completed
- Conditions
- Metastatic Castration-resistant Prostate Cancer
- Interventions
- Drug: 1.1 GBq (30 mCi) of 177Lu-P17-087Drug: 1.1 GBq (30 mCi) of 177Lu-P17-088
- First Posted Date
- 2022-11-02
- Last Posted Date
- 2023-10-23
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 9
- Registration Number
- NCT05603559
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China
Renal Perfusion Assessment in the Endovascular Treatment of Renal Artery Stenosis
Recruiting
- Conditions
- Renal Artery Stenosis
- First Posted Date
- 2022-11-02
- Last Posted Date
- 2022-11-02
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT05603221
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, China
Circulating Tumor DNA-guided Neoadjuvant Treatment Strategy for Locally Advanced Rectal Cancer
Phase 2
Recruiting
- Conditions
- Locally Advanced Rectal CarcinomaCirculating Tumor DNA
- Interventions
- Other: circulating tumor DNA
- First Posted Date
- 2022-11-01
- Last Posted Date
- 2024-12-24
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 470
- Registration Number
- NCT05601505
- Locations
- 🇨🇳
Department of General Surgery, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences,, Beijing, Beijing, China
© Copyright 2025. All Rights Reserved by MedPath